{"nct_id":"NCT00944034","title":"Safety, Tolerability and Immunogenicity of Meningococcal B Recombinant Vaccine Administered as Booster Dose at 12, 18 or 24 Months of Age in Toddlers (12-24 Months) Primed With a Three-Dose Immunization Series as Infants in Study V72P12","status":"COMPLETED","status_verified_date":"2017-07","start_date":"2009-07","start_date_type":null,"primary_completion_date":"2011-08","primary_completion_date_type":"ACTUAL","completion_date":"2012-01","completion_date_type":"ACTUAL","phases":["PHASE2","PHASE3"],"tickers":["NVS"]}